My Quote Request
No products added yet
6505-01-037-3145
20 Products
NDC54868-2306-00
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505010373145
NSN
6505-01-037-3145
NDC54868-2306-00
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505010373145
NSN
6505-01-037-3145
MFG
MEDICAL AND SAFETY GROUP INC DBA INDUSTRIAL DRUG SERVICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HALOPERIDOL TABLETS USP 10MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-1397-01
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505010373145
NSN
6505-01-037-3145
NDC00781-1397-01
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505010373145
NSN
6505-01-037-3145
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HALOPERIDOL TABLETS USP 10MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CORICIDIN TABLETS
CHLORPHENIRAMINE MALEATE AND ASPIRIN TABLETS
NSN, MFG P/N
6505010374425
NSN
6505-01-037-4425
CORICIDIN TABLETS
CHLORPHENIRAMINE MALEATE AND ASPIRIN TABLETS
NSN, MFG P/N
6505010374425
NSN
6505-01-037-4425
MFG
SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 2.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00085-0171-08
CHLORPHENIRAMINE MALEATE AND ASPIRIN TABLETS
NSN, MFG P/N
6505010374425
NSN
6505-01-037-4425
NDC00085-0171-08
CHLORPHENIRAMINE MALEATE AND ASPIRIN TABLETS
NSN, MFG P/N
6505010374425
NSN
6505-01-037-4425
MFG
SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 2.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00088-1375-58
OXYBUTYNIN CHLORIDE TABLETS,USP
NSN, MFG P/N
6505010374427
NSN
6505-01-037-4427
NDC00088-1375-58
OXYBUTYNIN CHLORIDE TABLETS,USP
NSN, MFG P/N
6505010374427
NSN
6505-01-037-4427
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS OXYBUTYNIN CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYBUTYNIN CHLORIDE TABLETS USP 5MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00603-4975-32
OXYBUTYNIN CHLORIDE TABLETS,USP
NSN, MFG P/N
6505010374427
NSN
6505-01-037-4427
NDC00603-4975-32
OXYBUTYNIN CHLORIDE TABLETS,USP
NSN, MFG P/N
6505010374427
NSN
6505-01-037-4427
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS OXYBUTYNIN CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYBUTYNIN CHLORIDE TABLETS USP 5MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00641-4020-89
OXYBUTYNIN CHLORIDE TABLETS,USP
NSN, MFG P/N
6505010374427
NSN
6505-01-037-4427
NDC00641-4020-89
OXYBUTYNIN CHLORIDE TABLETS,USP
NSN, MFG P/N
6505010374427
NSN
6505-01-037-4427
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS OXYBUTYNIN CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYBUTYNIN CHLORIDE TABLETS USP 5MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC50111-0456-03
OXYBUTYNIN CHLORIDE TABLETS,USP
NSN, MFG P/N
6505010374427
NSN
6505-01-037-4427
NDC50111-0456-03
OXYBUTYNIN CHLORIDE TABLETS,USP
NSN, MFG P/N
6505010374427
NSN
6505-01-037-4427
MFG
SIDMAK LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS OXYBUTYNIN CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXYBUTYNIN CHLORIDE TABLETS USP 5MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
1520
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010374537
NSN
6505-01-037-4537
1520
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010374537
NSN
6505-01-037-4537
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
FLAVOR: ANY ACCEPTABLE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LAFAYETTE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 312.000 GRAMS OR 10.920 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
HD-200 PLUS
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010374537
NSN
6505-01-037-4537
HD-200 PLUS
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010374537
NSN
6505-01-037-4537
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
FLAVOR: ANY ACCEPTABLE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LAFAYETTE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 312.000 GRAMS OR 10.920 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00224-0128-12
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010374537
NSN
6505-01-037-4537
NDC00224-0128-12
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010374537
NSN
6505-01-037-4537
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
FLAVOR: ANY ACCEPTABLE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LAFAYETTE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 312.000 GRAMS OR 10.920 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00085-0584-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
NDC00085-0584-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
Related Searches:
NDC00258-3581-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
NDC00258-3581-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
MFG
FOREST LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
Related Searches:
NDC00603-5946-21
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
NDC00603-5946-21
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
MFG
CARDINAL HEALTH 100 INC DBA BINDLEY WESTERN TENNESSEE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
Related Searches:
THEO-DUR
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
THEO-DUR
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
Related Searches:
THEO-DUR TABLETS
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
THEO-DUR TABLETS
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375607
NSN
6505-01-037-5607
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
Related Searches:
NDC00085-0487-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375613
NSN
6505-01-037-5613
NDC00085-0487-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375613
NSN
6505-01-037-5613
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
Related Searches:
NDC00258-3584-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375613
NSN
6505-01-037-5613
NDC00258-3584-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375613
NSN
6505-01-037-5613
MFG
INWOOD LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
Related Searches:
NDC50111-0483-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375613
NSN
6505-01-037-5613
NDC50111-0483-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375613
NSN
6505-01-037-5613
MFG
SIDMAK LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
Related Searches:
THEO-DUR
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375613
NSN
6505-01-037-5613
THEO-DUR
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505010375613
NSN
6505-01-037-5613
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING
